Showing results (21-30 of 136) with videos related to

Sort By:
Pageof 14
Drugs of Today (Barcelona, Spain : 1998)|February 10, 2009
Ambrisentan and its role in the management of pulmonary arterial hypertensionIain M Macintyre, Neeraj Dhaun, Jane Goddard, et al.
British Journal of Pharmacology|November 14, 2019
Established and emerging therapeutic uses of PDE type 5 inhibitors in cardiovascular diseaseNikolaos Tzoumas, Tariq E Farrah, Neeraj Dhaun, et al.
Drugs of Today (Barcelona, Spain : 1998)|October 11, 2008
Sitaxsentan sodium for pulmonary hypertensionIain M MacIntyre, Neeraj Dhaun, Jane Goddard, et al.
Kidney International Reports|April 4, 2017
Endemic Nephropathy Around the WorldFiona J Gifford, Robert M Gifford, Michael Eddleston, et al.
Trends in Pharmacological Sciences|October 24, 2007
Selective and mixed endothelin receptor antagonism in cardiovascular diseaseNeeraj Dhaun, David M Pollock, Jane Goddard, et al.
Kidney International|January 10, 2014
Utility of renal biopsy in the clinical management of renal diseaseNeeraj Dhaun, Christopher O Bellamy, Daniel C Cattran, et al.
British Journal of Clinical Pharmacology|June 28, 2013
Measurement of renal function in patients with chronic kidney diseaseEuan A Sandilands, Neeraj Dhaun, James W Dear, et al.
Seminars in Nephrology|May 13, 2015
Endothelin in nondiabetic chronic kidney disease: preclinical and clinical studiesGeoff J Culshaw, Iain M MacIntyre, Neeraj Dhaun, et al.
Current Hypertension Reports|August 6, 2013
Endothelin antagonism and its role in the treatment of hypertensionRebecca C Moorhouse, David J Webb, David C Kluth, et al.
Frontiers in Immunology|June 22, 2018
Neurological Disease in Lupus: Toward a Personalized Medicine ApproachSarah McGlasson, Stewart Wiseman, Joanna Wardlaw, et al.
Pageof 14